Biome Grow Provides Further Information on Supply and Production Agreement with Province of Newfoundland and Labrador
Biome Grow Inc. (CSE:BIO) announced Friday November 2, 2018 that its Newfoundland and Labrador brand, Back Home Cannabis Corporation (“Back Home”) has entered into a 24,000 kg three-year production and supply agreement (the “Supply Agreement”) with the Province of Newfoundland and Labrador (the “Transaction”) pursuant to which the Company anticipates annual revenues of up to approximately $100 million and recovery of $52 million through reduced remittances to the Newfoundland and Labrador Liquor Corporation (“NLC”), beginning in 2020.
The Company will achieve the expected $100 million in revenue per annum by virtue of wholesale distribution to the NLC at a wholesale price. This wholesale distribution coupled with the quantity to be supplied will account for a significant portion of the total revenue based on the expected prices to be received. A discount premium will be applied providing for an additional revenue stream with such discount premium to be shared initially by the Company and the NLC for a period of five years or collection by the Company of an aggregate of $52 million, following which, the NLC will receive the entirety of the discount premium (as discussed further below). There is also additional revenue to be gained through the retail stream and the operation by the Company of five retail stores anticipated to open prior to 2020, which will account for the remaining portion of expected revenues beginning in 2020. In generating the expected revenue of $100 million, the Company anticipates expenses of $50 million per year. This amount is comprised of (i) $30 million in direct production and operating costs such as direct salaries, power/utility costs, and input costs (including nutrients, water, growing medium); and (ii) $20 million in indirect facility and administrative costs such as administrative and non-production salaries, marketing costs, facility maintenance and balance of facility mechanical costs, retail support costs, financing expenses associated with the planned expansion, and accounting and legal expenses. Please see “Forward-looking Statements” and “Future Oriented Financial Information and Financial Outlook” below for further details.
Additionally, the Company plans to recover up to $52 million through reduced remittances to the NLC. Specifically, pursuant to the Supply Agreement, Biome can recoup eligible construction costs through reduced remittance to the NLC, with a set term of 5 years. To be more specific, in exchange for new jobs and the construction of a new production facility in the Province, Biome will receive a discount on the revenue it will provide monthly to the NLC. The Company will retain a portion of the NLC commission that will be considered the ‘premium’, or reduced remittances to the NLC, up to a maximum of $52 million over a five-year term. The $52 million dollar value is based on the assumption that the Company is able to successfully capture a large portion of the Newfoundland Labrador market for cannabis sales with such sales averaging in excess of $104 million per year (exclusive of tax), assuming competitive pricing and sales in Company-owned stores, third party-owned and licensed cannabis stores, as well as online. In exchange for the reduced remittances to the NLC, the Company will maintain 120 production jobs for a minimum of 20 years. This will be facilitated as a part of the $60 million expansion of Back Home’s production facility, which will be funded by utilizing existing cash on hand, as well as a mixture of debt and equity, assuming favourable market conditions, and if in the best interest of investors to do so.
For further information, please contact:
Biome wholly owns five subsidiaries, including: The Back Home Cannabis Corporation, a company incorporated under the laws of the Province of Newfoundland and Labrador and in the late stages of applying for a license under the ACMPR; Great Lakes Cannabis, a company incorporated under the laws of the Province of Ontario and in the late stages of applying for a license under the ACMPR; Highland Grow Inc., a licensed producer in Nova Scotia under Canada’s ACMPR; Red Sands Craft Cannabis Co., a company incorporated under the laws of the Province of Prince Edward Island, and; Weed Virtual Retail Inc., a company incorporated under the laws of the Province of Ontario in the business of operating a new virtual reality technology platform focused exclusively on the medical and recreational cannabis markets. Biome is a Canadian-based company with national and international business interests.
This news release contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as “plans”, “ expects” or “does not expect”, “proposed”, “is expected”, “budgets”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward‐looking statements and information concerning: the Transaction and the expected revenue to be derived from the Supply Agreement; the construction, timing and funding associated with such construction and expansion of Back Home’s facility in the Province of Newfoundland and Labrador; Back Home’s expected timeline for the production of cannabis; the expected operating lifetime of Back Home’s facility in the Province of Newfoundland and Labrador; investment in, and the development of, Back Home’s retail locations prior to 2020; the anticipated creation of jobs at Back Home’s production facility and retail locations and for the time periods stated; Biome’s expected investment in research and development; the Company’s investment in the provincial cannabis ecosystem and its ability to ensure Biome’s cannabis products are eligible for sale in the Province through the Newfoundland and Labrador supply chain, and Biome’s management and its business plans. Such forward-looking statements and information reflect management’s current beliefs and are based on assumptions made by and information currently available to Biome, including, among other things, assumptions and expectations with respect to: Back Home’s ability to obtain all necessary regulatory licenses, permits and approvals to produce and sell cannabis and generally operate its business; that labour, construction, and other costs will remain low for Back Home’s licensed cannabis production facilities; and that sufficient financial resources will be available.
These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements, including, among other things: a failure to obtain or delays in obtaining the required regulatory licenses, permits, or approvals; changes to legislation; changes in cannabis research or the general public’s perception of cannabis; crop failure; labour disputes; increases in labour and/or construction costs; rising energy costs; an inability to access financing as needed; and general economic downturn.
Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements speak only as of the date on which they are made, and Biome, or any of its subsidiaries undertakes no obligation to update or revise any forward looking statements whether as a result of new information, future events or otherwise, except as
required by law. The forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
Future Oriented Financial Information and Financial Outlook
This news release, and in particular the information provided in respect of the Company’s expected revenues beginning in 2020, also contains future-oriented financial information and financial outlook information (collectively, “FOFI”) within the meaning of applicable securities law. The FOFI is subject to the same assumptions, risk factors, limitations, and qualifications as set forth in the above paragraphs, in addition to assumptions with respect to the prices to be paid for the Company’s products, the costs and expenditures to be incurred by the Company and the costs associated with production, including direct production costs and indirect facility and administrative costs as detailed above, taxation rates, and other general and administrative expenses. The expected $100 million in revenue is specifically based on the assumption that the aggregate price, consisting of the supplier cost (wholesale), LP discount (premium), excise tax and HST is as expected. Additional assumptions related to this revenue forecast include that the Company will be able to functionally grow the quantity of cannabis at the dates required under the Supply Agreement and that the NLC will acquire the product at the prices expected. Furthermore, the statements relating to the retail sales assumes the retail locations are opened on the terms expected, that the products distributed in those locations will sell at the quantities anticipated and that a variety of products will be available in store and online and at the prices that are competitive in the market. FOFI contained in this news release was made as of the date of this news release and was provided by management for the purpose of providing further information about Biome’s future business operations. The Company believes that the FOFI has been prepared on a reasonable basis, reflecting management’s best estimates and judgments. However, because this information is highly subjective and subject to numerous risks including the risks discussed herein and above, it should not be relied on as necessarily indicative of future results. The actual results of operations of the Company and the resulting financial results may vary from the amounts set forth herein, and such variations may be material. Biome disclaims any intention or obligation to update or revise any FOFI contained in this news release, whether as a result of new information, future events or otherwise, except as required by applicable securities law. Investors are cautioned that the FOFI contained in this news release should not be used for purposes other than for which it is disclosed herein.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).